CAS: 1443437-74-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]- REF: IN-DA001JDDCAS: 1443437-74-8 | 98% | 76.00 €~635.00 € | Thu 09 Jan 25 |
 | CCG-203971 REF: TM-T4306CAS: 1443437-74-8 | 98.82% - 99.35% | To inquire | Thu 16 Jan 25 |
 | CCG 203971 REF: 3D-FC76600CAS: 1443437-74-8 | Min. 95% | To inquire | Thu 20 Feb 25 |
![3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001JDD.jpg)
3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-
CAS:1443437-74-8
Formula:
C23H21ClN2O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
408.8774
Ref: IN-DA001JDD
| 1g | 635.00 € | ||
| 5mg | 76.00 € | ||
| 10mg | 109.00 € | ||
| 25mg | 152.00 € | ||
| 100mg | 164.00 € | ||
| 250mg | 261.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
CCG-203971
CAS:1443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: …
Formula:
C23H21ClN2O3
Purity:
98.82% - 99.35%
Color and Shape:
Solid
Molecular weight:
408.88
Ref: TM-T4306
| 10mg | 53.00 € | ||
| 25mg | 94.00 € | ||
| 50mg | 144.00 € | ||
| 100mg | 224.00 € | ||
| 500mg | 553.00 € | ||
| 1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
CCG 203971
CAS:1443437-74-8
Inhibits MRTF-SRF transcriptional pathway
Formula:
C23H21ClN2O3
Purity:
Min. 95%
Molecular weight:
408.88 g/mol
Ref: 3D-FC76600
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Feb 2025
